Promentis Pharmaceuticals, based in Milwaukee, WI, focuses on developing innovative therapeutics for central nervous system disorders. The company leverages cutting-edge research in pharmaceuticals and biotechnology to address unmet medical needs, aiming to enhance the quality of life for patients through effective treatment solutions.
What industry does Promentis Pharmaceuticals belong to?
Promentis Pharmaceuticals belongs to the Pharmaceuticals, Biotechnology and Life Sciences industry.
What are the specialties of Promentis Pharmaceuticals?
Promentis Pharmaceuticals specializes in Innovative neuropsychiatric therapies, Treatment for trichotillomania, Glutamate signaling research, Central nervous system disorders, Obsessive-compulsive disorder solutions.
What products and services is Promentis Pharmaceuticals likely to offer?
Promentis Pharmaceuticals offers Neuropsychiatric therapies, Trichotillomania treatment, CNS disorder medications, Research in glutamate signaling, Innovative biopharmaceutical solutions.
Who are the competitors of Promentis Pharmaceuticals?
Competitors of Promentis Pharmaceuticals are Neurocrine Biosciences, Axovant Gene Therapies, Otsuka Pharmaceutical, Sage Therapeutics, Alkermes, Cambrex, Jazz Pharmaceuticals, Intra-Cellular Therapies.
What does Promentis Pharmaceuticals do?
Promentis Pharmaceuticals, based in Milwaukee, WI, focuses on developing innovative therapeutics for central nervous system disorders. The company leverages cutting-edge research in pharmaceuticals and biotechnology to address unmet medical needs, aiming to enhance the quality of life for patients through effective treatment solutions.
What are the social media links of Promentis Pharmaceuticals?
Social media links of Promentis Pharmaceuticals areLinkedIn